A M Aalbers1, V H J van der Velden2, A Yoshimi3, A Fischer3, P Noellke3, C M Zwaan4, I Baumann5, H B Beverloo6, M Dworzak7, H Hasle8, F Locatelli9, B De Moerloose10, G Göhring11, M Schmugge12, J Stary13, M Zecca14, A W Langerak2, J J M van Dongen2, R Pieters4, C M Niemeyer3, M M van den Heuvel-Eibrink4. 1. 1] Department of Pediatric Oncology/Hematology, Sophia Children's Hospital-Erasmus University Medical Center, Rotterdam, The Netherlands [2] Department of Immunology, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands. 2. Department of Immunology, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands. 3. Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany. 4. Department of Pediatric Oncology/Hematology, Sophia Children's Hospital-Erasmus University Medical Center, Rotterdam, The Netherlands. 5. Department of Pathology, Clinical Centre South West, Böblingen Clinics, Böblingen, Germany. 6. Department of Clinical Genetics, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands. 7. St. Anna Children's Hospital and Children's Cancer Research Institute, Department of Pediatrics, Medical University of Vienna, Vienna, Austria. 8. Department of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark. 9. Department of Pediatric Hematology-Oncology, IRCCS Ospedale Bambino Gesù, Rome, University of Pavia, Rome, Italy. 10. Department of Pediatric Hematology/Oncology, Ghent University Hospital, Ghent, Belgium. 11. Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany. 12. Department of Hematology, University Children's Hospital, Zurich, Switzerland. 13. Department of Pediatric Hematology/Oncology, Charles University and University Hospital Motol, Prague, Czech Republic. 14. Pediatric Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Authors: D E Dunn; P Tanawattanacharoen; P Boccuni; S Nagakura; S W Green; M R Kirby; M S Kumar; S Rosenfeld; N S Young Journal: Ann Intern Med Date: 1999-09-21 Impact factor: 25.391
Authors: J P Maciejewski; D Follmann; R Nakamura; Y Saunthararajah; C E Rivera; T Simonis; K E Brown; J A Barrett; N S Young Journal: Blood Date: 2001-12-15 Impact factor: 22.113
Authors: D J Araten; M Bessler; S McKenzie; H Castro-Malaspina; B H Childs; F Boulad; A Karadimitris; R Notaro; L Luzzatto Journal: Leukemia Date: 2002-11 Impact factor: 11.528
Authors: Anna M Aalbers; Marry M van den Heuvel-Eibrink; Irith Baumann; Michael Dworzak; Henrik Hasle; Franco Locatelli; Barbara De Moerloose; Markus Schmugge; Ester Mejstrikova; Michaela Nováková; Marco Zecca; C Michel Zwaan; Jeroen G Te Marvelde; Anton W Langerak; Jacques J M van Dongen; Rob Pieters; Charlotte M Niemeyer; Vincent H J van der Velden Journal: Haematologica Date: 2014-11-25 Impact factor: 9.941
Authors: Yash B Shah; Salvatore F Priore; Yimei Li; Chi N Tang; Peter Nicholas; Peter Kurre; Timothy S Olson; Daria V Babushok Journal: Blood Adv Date: 2021-08-24
Authors: Fiona Poyer; Raúl Jimenez Heredia; Wolfgang Novak; Petra Zeitlhofer; Karin Nebral; Michael N Dworzak; Oskar A Haas; Kaan Boztug; Leo Kager Journal: Front Immunol Date: 2022-06-24 Impact factor: 8.786
Authors: A M Aalbers; M M van den Heuvel-Eibrink; I Baumann; H B Beverloo; G J Driessen; M Dworzak; A Fischer; G Göhring; H Hasle; F Locatelli; B De Moerloose; P Noellke; M Schmugge; J Stary; A Yoshimi; M Zecca; C M Zwaan; J J M van Dongen; R Pieters; C M Niemeyer; V H J van der Velden; A W Langerak Journal: Blood Cancer J Date: 2014-05-02 Impact factor: 11.037